The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Bristol-Myers Squibb; Roche Pharma AG; URGO MEDICAL
Speakers' Bureau - Bristol-Myers Squibb; Roche Pharma AG

Phase II multicentric uncontrolled national trial assessing the efficacy of nilotinib in the treatment of advanced melanomas with c-KIT mutation or amplification: Results of the pharmacodynamic study.
 
Elodie Lesteven
No Relationships to Disclose
 
Maxime Battistella
Consulting or Advisory Role - Roche Pharma AG
 
Thomas Jouary
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Roche Pharma AG
Consulting or Advisory Role - GlaxoSmithKline; MSD; Roche Pharma AG
Travel, Accommodations, Expenses - Roche Pharma AG
 
Sophie Dalac
No Relationships to Disclose
 
Stephane Dalle
Employment - Sanofi (I)
Research Funding - Roche Pharma AG (Inst)
Travel, Accommodations, Expenses - Roche Pharma AG
 
Bernard Guillot
No Relationships to Disclose
 
Jean-Philippe Arnault
No Relationships to Disclose
 
Marie-Françoise Avril
Consulting or Advisory Role - Roche
Travel, Accommodations, Expenses - Roche Pharma AG
 
Christophe Bedane
No Relationships to Disclose
 
Guido Bens
No Relationships to Disclose
 
Marie- Beylot-Barry
Consulting or Advisory Role - Roche Pharma AG
 
Florent Grange
No Relationships to Disclose
 
Nicolas Meyer
Leadership - Amgen; Bristol-Myers Squibb; Roche Pharma AG
Honoraria - Bristol-Myers Squibb; Roche Pharma AG
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Roche Pharma AG
Expert Testimony - Amgen; Bristol-Myers Squibb; Roche Pharma AG
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche Pharma AG
 
Laurent Machet
No Relationships to Disclose
 
Philippe Saiag
Honoraria - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; MSD; Roche Pharma AG
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; MSD; Roche Pharma AG
Speakers' Bureau - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; MSD; Roche Pharma AG
Research Funding - Roche Pharma AG
 
Nicolas Dumaz
No Relationships to Disclose
 
Samia Mourah
Honoraria - Roche Pharma AG
Consulting or Advisory Role - GlaxoSmithKline; Novartis; Roche Pharma AG
 
Celeste Lebbe
Honoraria - Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis
Travel, Accommodations, Expenses - Roche